Skip to main content
PHG logo

Koninklijke Philips N.V. (PHG) Stock Price & Analysis

Koninklijke Philips N.V. (PHG) — MoonshotScore 78/100 (Strong band), calculated Nov 18, 2026. Price $29.27 (-1.81%), as of the Nov 19, 2026 trading session; market cap $28.6B.

Educational signal · not a buy or sell recommendation · How to read this

$29.27 −$0.54 (-1.81%) Market Cap $28.6B

Koninklijke Philips N.V. · PHG · NYSE · Healthcare · Medical - Devices

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other.

Price as of Nov 19, 2026

Key Statistics

78 of 100

MoonshotScore v2 · Koninklijke Philips (PHG)

Strong
Business Quality Solid (79)
Financial Safety Okay (45)
Valuation Fair (74)
Growth Durability Growing (75)
Momentum Surging (83)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

High quality and durable growth, though the balance sheet is only middling; the market is already moving on it. Business Quality: Solid; Financial Safety: Okay; Valuation: Fair; Growth Durability: Growing; Momentum: Surging.

  • quarterly revenue €4.37B (Q3 FY2026, quarter ended Sep 2026)
  • EPS beat 6 of the last 8 reports
  • Altman Z 2.07 · Piotroski F 7

Helping: business quality, an attractive price, durable growth, positive momentum

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for PHG (52 recorded, newest six shown)
RecordedScoreBand
76Strong
77Strong
77Strong
77Strong
78Strong
78Strong

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$29.27
Change on the day-1.81%
52-week range$23.62–$33.44
Market capitalisation$28.6B—
Price / earnings (trailing)26.96
Shares traded on the day1.46M
Beta (volatility vs the S&P 500)0.92

Price & events

Weekly closing price with reported quarters marked Weekly closing price from Oct 17, 2025 to Nov 19, 2026: low $24, high $32, latest $29. $32 $24 high $32 Oct 17, 2025 Nov 19, 2026 · $29 $29Oct 17, 2025$27Oct 31, 2025$29Nov 14, 2025$28Nov 28, 2025$27Dec 12, 2025$27Dec 26, 2025$30Jan 9, 2026$29Jan 23, 2026$29Feb 6, 2026$31Feb 20, 2026$29Mar 6, 2026$26Mar 20, 2026$27Apr 2, 2026$30Apr 17, 2026$26May 1, 2026$25May 15, 2026$26May 29, 2026$26Jun 12, 2026$27Jun 26, 2026$27Jul 10, 2026$26Jul 24, 2026$27Aug 7, 2026$27Aug 21, 2026$26Sep 4, 2026$25Sep 18, 2026$24Oct 2, 2026$26Oct 16, 2026$27Oct 30, 2026$30Nov 13, 2026

Point at or tab to any week for its close.

Other perspectives

Council score for Koninklijke Philips (PHG): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Business Quality Moderate
Financial Safety Neutral
Valuation Moderate
Growth Durability Moderate
Momentum Strong

Legends Council

6 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Favorable read
Simons-style lens (simulated) Jim Simons Favorable read
Englander-style lens (simulated) Izzy Englander Favorable read
Klarman-style lens (simulated) Seth Klarman Neutral read
Moon AI lens (model) Favorable read

Read on: Nov 18, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Neutral
Margin of Safety Undervalued
Profit Margin Neutral
Revenue Growth Negative
Debt/Equity Weak
ROE Neutral
Gross Margin Moderate

Read on: Nov 17, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Nov 17, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is Koninklijke Philips (PHG), and what does it report?

Short answer

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. Koninklijke Philips N.V. (PHG) is listed on NYSE. Healthcare / Medical Devices SEC filing business address: Prinses Irenestraat 59, Amsterdam, 1077WV. It employs 66,401 people and is led by Roy W. O. Jakobs. In Q3 FY2026 it reported revenue of €4.37B and net income of €27M. The market values it at $28.6B.

2 · Latest results

What do the latest results show for Koninklijke Philips (PHG)?

Short answer · as of

The most recent reported quarter, Q3 FY2026, carried revenue of €4.37B. Against analyst estimates the company has EPS beat 6 of the last 8 reports.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q3 FY2026€4.37B€27M€0.03 (diluted)
Q2 FY2026€4.36B€384M€0.40 (diluted)
Q1 FY2026€3.90B€151M€0.16 (diluted)
Q4 FY2025€5.10B€395M€0.41 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Koninklijke Philips (PHG)?

Short answer · as of

The MoonshotScore pillars rate business quality, an attractive price, durable growth, positive momentum as strengths. The distress and quality screens read Altman Z 2.07 · Piotroski F 7. Trailing ratios: ROE 8.4% · ROA 3.4% · current ratio 1.33 · earnings yield 3.6% · free-cash-flow yield 7.8%.

5 · Peer comparison

How does Koninklijke Philips compare with its peers?

Short answer

Koninklijke Philips's score ranks 10th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Research dated 2026-09-12.

Unlike a focused hospital equipment vendor, Philips combines diagnostic and treatment platforms with monitoring, respiratory care, enterprise informatics, and branded consumer health products. Its results therefore reflect purchasing by health systems as well as demand for oral care, personal care, and mother-and-child products.

That breadth makes product mix economically important: which Philips products sell matters alongside how much the company sells. Management's warning about unfavorable mix confirms that shifts within the portfolio can pressure margins even without a broad revenue contraction.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
DexCom, Inc. (DXCM) Named competitor$80.19 Nov 19, 2026$29.9B93 5-pillar Nov 18, 2026
Mettler-Toledo International Inc. (MTD) Named competitor$1737.26 Nov 18, 2026$34.6B93 5-pillar Nov 18, 2026
Edwards Lifesciences Corporation (EW) Same industry, near in market value$105.23 Nov 18, 2026$60.5B93 5-pillar Nov 18, 2026
Penumbra, Inc. (PEN) Same industry, near in market value$320.00 Nov 19, 2026$12.6B92 5-pillar Nov 18, 2026
STERIS plc (STE) Same industry, near in market value$259.57 Nov 18, 2026$25.2B87 5-pillar Nov 18, 2026
Insulet Corporation (PODD) Same industry, near in market value$139.98 Nov 18, 2026$9.71B85 5-pillar Nov 18, 2026
Smith & Nephew plc (SNN) Same industry, near in market value$30.32 Nov 18, 2026$12.7B84 5-pillar Nov 18, 2026
Align Technology, Inc. (ALGN) Same industry, near in market value$163.96 Nov 18, 2026$11.6B83 5-pillar Nov 18, 2026
Zimmer Biomet Holdings, Inc. (ZBH) Same industry, near in market value$103.32 Nov 18, 2026$19.6B79 5-pillar Nov 18, 2026
Koninklijke Philips (PHG) — this page$29.27$28.6B78
Boston Scientific Corporation (BSX) Same industry, near in market value$43.64 Nov 18, 2026$63.3B77 5-pillar Nov 18, 2026
Bio-Rad Laboratories, Inc. (BIO) Same industry, near in market value$370.17 Nov 18, 2026$9.95B77 5-pillar Nov 18, 2026
Teva Pharmaceutical Industries Limited (TEVA) Named competitor$42.23 Nov 18, 2026$49.3B57 5-pillar Nov 18, 2026

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

Screen more Healthcare stocks

The records behind this page

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held PHG in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported PHG in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about Koninklijke Philips (PHG)?

Read these with our analysis →

What Investors Ask About Koninklijke Philips (PHG) — Healthcare

The last question is answered from this page's own dated data, not from the research.

What does Philips sell beyond diagnosis and treatment systems?

Philips also supplies patient monitoring, sleep and respiratory care, and enterprise informatics, while Personal Health covers oral care, personal care, and mother-and-child products.

What is pressuring Philips adjusted margin?

Management identifies input-cost inflation, annualized tariffs, and an unfavorable product mix as offsets to innovation, productivity, and sales growth.

How does Philips Personal Health change its business exposure?

Personal Health adds oral care, personal care, and mother-and-child products to a portfolio otherwise centered on hospital systems, clinical devices, software, and care services. Philips is therefore not a pure hospital-equipment business.

What is the PHG stock price today?

The last price recorded for Koninklijke Philips N.V. (PHG), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

Research written by Codex (gpt-5.6-sol) on 2026-09-12. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 20 figures on this page — 1 from SEC filings and earnings calls, 14 from Financial Modeling Prep (FMP), 4 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections

Sources (as of 2026-09-12), by section of the research

  • 5. How does Koninklijke Philips compare with its peers?: Sector / industry (provider taxonomy); Business description; Management outlook — dated call excerpts
  • FAQ: What does Philips sell beyond diagnosis and treatment systems?: Business description
  • FAQ: What is pressuring Philips adjusted margin?: Management outlook — dated call excerpts
  • FAQ: How does Philips Personal Health change its business exposure?: Business description; Sector / industry (provider taxonomy)
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.

ETFs that hold PHG

Funds in our ETF coverage that list PHG among the top 10 holdings on their fund page, largest weight first. Each weight is the fund's reported holding weight as of the date in its row.

ETFWeightHoldings as of
LGHT ETF6.53%